S. H. Kim

发表

The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease.

N. Cairns, R. Vlkolinský, G. Lubec, 2001, Life sciences.

Characterization of a Presenilin-mediated Amyloid Precursor Protein Carboxyl-terminal Fragment γ

S. H. Kim, L. Gasparini, Chunjiang Yu, 2001, The Journal of Biological Chemistry.

Decreased alpha-endosulfine, an endogenous regulator of ATP-sensitive potassium channels, in brains from adult Down syndrome patients.

G. Lubec, S. H. Kim, 2001, Journal of neural transmission. Supplementum.

Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV)

G. Lubec, S. H. Kim, M. Cheon, 2003, Amino Acids.

Familial British Dementia: Expression and Metabolism of BRI

D. Steiner, J. Bass, S. H. Kim, 2000, Annals of the New York Academy of Sciences.

S. H. Kim, S. Kim, S. Jeong, 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

Function and dysfunction of the presenilins.

S. H. Kim, S. Sisodia, G. Thinakaran, 1999, American journal of human genetics.

Widespread increased expression of the DNA repair enzyme PARP in brain in ALS

S. H. Kim, S. Appel, J. Henkel, 2004, Neurology.

Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains.

M. Dierssen, G. Lubec, S. H. Kim, 2001, Journal of neural transmission. Supplementum.

Mutation screening of the neurogenin-3 gene in autosomal dominant diabetes.

A. Krolewski, A. Doria, S. H. Kim, 2001, Journal of Clinical Endocrinology and Metabolism.

Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome.

M. Hur, S. H. Kim, Y. R. Kim, 2004, Clinical and laboratory haematology.

Protein expression of BACE1, BACE2 and APP in Down syndrome brains

M. Dierssen, G. Lubec, S. H. Kim, 2008, Amino Acids.

Decreased levels of complex III core protein 1 and complex V β chain in brains from patients with Alzheimer’s disease and Down syndrome

N. Cairns, R. Vlkolinský, G. Lubec, 2000, Cellular and Molecular Life Sciences CMLS.

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

J. Kaplan, A. Beggs, K. North, 2000, Nature genetics.

Gamma-secretase: never more enigmatic.

B. de Strooper, W. Annaert, S. H. Kim, 2001, Trends in neurosciences.

A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13.

J. Seidman, C. Seidman, M. Haas, 1998, Kidney international.

Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part II)

A. Stewart, G. Lubec, M. Bajo, 2003, Amino Acids.

Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part I)

M. Yaspo, G. Lubec, S. H. Kim, 2003, Amino Acids.

Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part III)

T. Ijuin, G. Lubec, S. H. Kim, 2003, Amino Acids.

Chromosomal non-disjunction in human oocytes: is there a mitochondrial connection?

E. Schon, P. Magalhães, J. Ferreira, 2000, Human reproduction.

Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.

N. Cairns, G. Lubec, S. H. Kim, 2001, Journal of neural transmission. Supplementum.

Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13.

A. Doria, S. H. Kim, V. Trischitta, 2004, Physiological genomics.

Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains.

M. Dierssen, G. Lubec, S. H. Kim, 2001, Journal of neural transmission. Supplementum.

Expression of Alzheimer's amyloid precursor protein in human lymphocyte.

J. S. Kim, S. H. Kim, Y. Chong, 1997, Archives of gerontology and geriatrics.

Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease.

A. Nairn, N. Cairns, G. Lubec, 2001, Journal of neural transmission. Supplementum.

Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.

N. Cairns, B. Yoo, J. Broers, 2000, Biochemical and biophysical research communications.

Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease.

G. Lubec, S. H. Kim, M. Fountoulakis, 2003, Journal of neural transmission. Supplementum.

Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.

N. Cairns, B. Yoo, G. Lubec, 2001, Biochemical and biophysical research communications.